Who owns AAVL - AVALANCHE BIOTECHNOLOGIES IN - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

AVALANCHE BIOTECHNOLOGIES IN - COM (AAVL) Institutional Ownership

Q: What is CUSIP 05337G107?

CUSIP 05337G107 is the security identifier used in SEC filing datasets for AAVL - AVALANCHE BIOTECHNOLOGIES IN - COM.

CUSIP: 05337G107

13F Institutional Holders and Ownership History from Q3 2014 to Q2 2016

Type / Class: Equity / COM
Symbol: AAVL

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 05337G107?
CUSIP 05337G107 identifies AAVL - AVALANCHE BIOTECHNOLOGIES IN - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 05337G107:

Q2 2016 (0 holders) Q1 2016 (76 holders) Q4 2015 (74 holders) Q3 2015 (90 holders) Q2 2015 (94 holders) Q1 2015 (111 holders) Q4 2014 (83 holders) Q3 2014 (58 holders)

Institutional Holders of AVALANCHE BIOTECHNOLOGIES IN - COM (AAVL) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2016 Q2	0	$0	-$78,964,222	$0	$0		0
2016 Q1	15,275,183	$78,969,220	-$11,332,656	$1,105,000	$158,000	$5.17	76
2015 Q4	16,069,217	$152,980,086	-$11,207,736	$2,086,000	$1,249,000	$9.52	74
2015 Q3	17,435,479	$143,669,248	+$4,723,424	$4,083,000	$1,757,000	$8.24	90
2015 Q2	15,712,922	$255,175,334	-$139,341,078	$6,831,000	$20,706,000	$16.24	94
2015 Q1	15,859,361	$641,579,016	+$75,031,347	$3,266,000	$12,836,000	$40.52	111
2014 Q4	13,515,695	$726,529,306	+$51,749,034			$54.00	83
2014 Q3	12,525,268	$420,320,000	+$420,320,000			$34.19	58